NO812762L - Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser. - Google Patents

Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser.

Info

Publication number
NO812762L
NO812762L NO812762A NO812762A NO812762L NO 812762 L NO812762 L NO 812762L NO 812762 A NO812762 A NO 812762A NO 812762 A NO812762 A NO 812762A NO 812762 L NO812762 L NO 812762L
Authority
NO
Norway
Prior art keywords
polyazaheterocyclic
compounds
procedure
preparation
new
Prior art date
Application number
NO812762A
Other languages
English (en)
Norwegian (no)
Inventor
Joerg Frei
Ernst Schweizer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO812762L publication Critical patent/NO812762L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/16—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO812762A 1980-08-15 1981-08-14 Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser. NO812762L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH619780 1980-08-15

Publications (1)

Publication Number Publication Date
NO812762L true NO812762L (no) 1982-02-16

Family

ID=4305798

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812762A NO812762L (no) 1980-08-15 1981-08-14 Fremgangsmaate til fremstilling av nye polyazaheterocykliske forbindelser.

Country Status (16)

Country Link
EP (1) EP0046446A1 (mo)
JP (1) JPS5754186A (mo)
KR (1) KR830006293A (mo)
AU (1) AU7409281A (mo)
CA (1) CA1173831A (mo)
DD (1) DD201594A5 (mo)
DK (1) DK362381A (mo)
ES (1) ES504736A0 (mo)
FI (1) FI812518A7 (mo)
GB (1) GB2082577B (mo)
GR (1) GR78233B (mo)
IE (1) IE51498B1 (mo)
IL (1) IL63572A0 (mo)
NO (1) NO812762L (mo)
PT (1) PT73523B (mo)
ZA (1) ZA815621B (mo)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188609A (ja) * 1984-03-07 1985-09-26 株式会社スリ−ボンド セルフロッキングねじ部材の製造方法
JPS61167711A (ja) * 1985-01-17 1986-07-29 株式会社 スリ−ボンド セルフロツキング剤及びセルフロツキングねじ部材
DE3730718A1 (de) * 1987-09-12 1989-03-23 Basf Ag Tetracyclische chinazolinderivate, herstellung und verwendung
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422807A (de) * 1963-08-16 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung von Imidazo- und Pyrimidochinazolinen
US3329679A (en) * 1965-12-22 1967-07-04 American Home Prod Fused-ring imidazoquinazolines, pyrimidoquinazolines and related compounds

Also Published As

Publication number Publication date
ZA815621B (en) 1982-08-25
DK362381A (da) 1982-02-16
KR830006293A (ko) 1983-09-20
IE51498B1 (en) 1987-01-07
PT73523A (en) 1981-09-01
GB2082577A (en) 1982-03-10
PT73523B (en) 1983-08-16
IL63572A0 (en) 1981-11-30
AU7409281A (en) 1982-02-18
ES8204992A1 (es) 1982-05-16
DD201594A5 (de) 1983-07-27
FI812518L (fi) 1982-02-16
CA1173831A (en) 1984-09-04
IE811860L (en) 1982-02-15
ES504736A0 (es) 1982-05-16
JPS5754186A (mo) 1982-03-31
GB2082577B (en) 1984-03-28
FI812518A7 (fi) 1982-02-16
GR78233B (mo) 1984-09-26
EP0046446A1 (de) 1982-02-24

Similar Documents

Publication Publication Date Title
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
NO156828B (no) Analogifremgangsmaate for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
NO833705L (no) Fremgangsmaate for fremstilling av fenyl-piperidin-propanol-forbindelser.
NO831792L (no) Fremgangsmaate til fremstilling av nye imidazo-pyrazolopyrimidiner
FI810505A7 (fi) Menetelmä 3-jodimetyylikefalosporiinien valmistamiseksi.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO814047L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO800570L (no) Fremgangsmaate til fremstilling av store islegemer
NO158743C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive mitosanforbindelser.
NO812701L (no) Fremgangsmaate for fremstilling av antibakterielle timetyl-cefalosporiner.
NO813814L (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO157652C (no) Fremgangsmaate for fremstilling av 3-pikolin.
NO155732C (no) Fremgangsmaate for fremstilling av kijanimicin.
NO158422C (no) Analogifremgangsmaate ved fremstilling av nye oksadiazolopyrimidin-derivater.
NO154193C (no) Fremgangsmaate for fremstilling av monohydratisert picotamid
NO811038L (no) Fremgangsmaate til fremstilling av insulin.
NO800251L (no) Fremgangsmaate til fremstilling av beta-laktamforbindelser
NO822185L (no) Fremgangsmaate for fremstilling av nye derivater av benzoylfenylpiperidin.
NO842385L (no) Fremgangsmaate til fremstilling av nye benzofenoner.
NO800249L (no) Fremgangsmaate til stabilisering av nye halogenerende forbindelser.
NO810838L (no) Fremgangsmaate ved fremstilling av nye steroid-spiro-oxathiazolidinderivater
NO853450L (no) Fremgangsmaate til fremstilling av sulfonderivater